• 제목/요약/키워드: Bowel morbidity

검색결과 33건 처리시간 0.028초

Simultaneous resection of synchronous colorectal liver metastasis: Feasibility and development of a prediction model

  • Mufaddal Kazi;Shraddha Patkar;Prerak Patel;Aditya Kunte;Ashwin Desouza;Avanish Saklani;Mahesh Goel
    • 한국간담췌외과학회지
    • /
    • 제27권1호
    • /
    • pp.40-48
    • /
    • 2023
  • Backgrounds/Aims: Timing of resection for synchronous colorectal liver metastasis (CRLM) has been debated for decades. The aim of the present study was to assess the feasibility of simultaneous resection of CRLM in terms of major complications and develop a prediction model for safe resections. Methods: A retrospective single-center study of synchronous, resectable CRLM, operated between 2013 and 2021 was conducted. Upper limit of 95% confidence interval (CI) of major complications (≥ grade IIIA) was set at 40% as the safety threshold. Logistic regression was used to determine predictors of morbidity. Prediction model was internally validated by bootstrap estimates, Harrell's C-index, and correlation of predicted and observed estimates. Results: Ninety-two patients were operated. Of them, 41.3% had rectal cancers. Major hepatectomy (≥ 4 segments) was performed for 25 patients (27.2%). Major complications occurred in 20 patients (21.7%, 95% CI: 13.8%-31.5%). Predictors of complications were the presence of comorbidities and major hepatectomy (area under the ROC curve: 0.692). Unacceptable level of morbidity (≥ 40%) was encountered in patients with comorbidities who underwent major hepatectomy. Conclusions: Simultaneous bowel and CRLM resection appear to be safe. However, caution should be exercised when combining major liver resections with bowel resection in patients with comorbid conditions.

골반부 방사선 조사야 내의 소장 용적을 줄이기 위한 Small Bowel Displacement System(SBDS)의 사용 (Minimization of Small Bowel Volume within Treatment Fields Using Customized Small Bowel Displacement System(SBDS))

  • 임도훈;허승재;안용찬;김대용;우홍균;김문경;최동락;신경환
    • Radiation Oncology Journal
    • /
    • 제15권3호
    • /
    • pp.263-268
    • /
    • 1997
  • 목적 : 저자들은 골반부 방사선 치료에 있어서 소장을 방사선 조사야 밖으로 밀어냄으로써 방사선치료로 인한 소장의 부작용을 최소화하고자 Small Bowel Displacement System (SBDS)을 만들어 환자 치료에 적용하였다. 대상 및 방법 : 1995년 5월부터 1996년 5월까지 SBDS를 이용하여 골반부에 방사선 치료를 받은 55명의 환자를 대상으로 하였다. SBDS는 환자의 하복부를 눌러줌으로써 골반부 내의 소장을 방사선 조사야 밖으로 밀어내는 Styrofoam compression device와 이로 인한 환자의 하복부 불편감을 줄이며 치료시 환자 자세의 안전성을 유지시키기 위해 환자 개개인별로 만든 Immobilization device로 구성된다. 모의치료시 소장을 조영제로 조영시킨 후 복와위 상태에서 SBOS를 사용하기 전과 사용한 후의 후방-전방 및 측방 촬영을 하여 방사선 조사야 내에 포함되는 조영제로 조영이 되는 소장의 면적을 측정하여 서로 비교하였다. 결과 : SBDS를 사용했을 때 사용전에 비하여 후방-전방 촬영 필름에서는 $59\%$의 소장이 그리고 측방 촬영 필름에서는 $51\%$의 소장이 방사선 조사야 밖으로 밀려났다(P=0.0001). 조영된 소장의 평균 상향 이동 거리는 4.8cm였으며, 55명의 환자중 단지 8명 $(15\%)$에서만 투약이 필요할 정도의 설사를 호소하였으며, 이로 인하여 방사선치료가 중단되거나 지연된 경우는 없었다. 결론: SBDS는 소장을 골반부 방사선 조사야 밖으로 효과적으로 밀어내는 기구로서 방사선 치료로 인한 소장의 부작용을 감소시키는 기구이다. 또한, 제작이 용이하며 환자 치료 자세의 높은 재현성을 보였다. SBDS를 사용한 환자에서 향후 방사선 만성 부작용의 발생 빈도 감소에 기여한다면 필요한 경우에 골반부에 조사하는 방사선량을 증가시켜 보다 향상된 치료효과를 기대할 수 있겠다.

  • PDF

재발된 위암 환자에서 발생한 악성 장폐쇄증의 수술적 치료 (The Surgical Treatment of Malignant Bowel Obstruction Caused by Recurrent Gastric Cancer)

  • 유병은;박중민;장유진;김종한;박성수;박성흠;김승주;목영재;김종석
    • Journal of Gastric Cancer
    • /
    • 제8권3호
    • /
    • pp.148-153
    • /
    • 2008
  • 목적: 위암의 재발로 발생한 악성 장폐쇄증은 치료의 효과와 생존율을 향상시키기 위하여 적합하게 치료되어야 한다. 본 연구에서는 위암으로 수술 후 재발되어 악성 장폐쇄증이 발생한 경우 수술 방법에 따른 치료 효과와 생존율의 차이를 알아보았다. 대상 및 방법: 1998년 1월부터 2008년 3월까지 위암의 재발로 악성 장폐쇄증이 발생하여 수술적 치료를 받은 환자들의 의무 기록을 후향적으로 분석하였다. 수술 방법은 절제술, 장루술, 우회술로 나누었고 치료의 성공은 유동식 이상의 경구 섭취가 가능한 것으로 보았다. 결과: 42명의 환자에 대해 46회의 수술이 시행되었으며 절제술이 12회, 장루술이 24회, 위회술이 10회이었다. 입원기간과 유동식 이상의 경구 섭취까지의 기간은 장루술이 가장 짧았다. 수술 후 합병증은 10예(21.7%)에서 있었고 수술 후 30일 이내에 사망한 경우는 4예(8.7%)이었다. 수술 방법에 따른 생존율의 차이는 없었다. 결론: 위암의 재발로 발생한 악성 장폐쇄증의 수술적 치료로 장루술은 입원일과 경구 섭취까지의 기간이 다른 수술법에 비해 짧기 때문에 일부 환자들에서 좋은 선택이 될 수 있다. 수술 방법에 따른 생존율의 차이는 없었으며 이는 악성 장폐쇄증의 경우 근치적 수술이 어려운 경우가 대부분이기 때문으로 생각된다.

  • PDF

소아 중장 염전의 임상 양상 (Clinical Features of the Midgut Volvulus in Children)

  • 김현아;최금자
    • Advances in pediatric surgery
    • /
    • 제10권2호
    • /
    • pp.112-116
    • /
    • 2004
  • Midgut volvulus secondary to intestinal malrotation usually presents within the first month of life. Diagnostic delay may result in midgut infarction and mortality. In this retrospective study, we review seventeen cases of midgut volvulus to assess the importance of early recognition for midgut volvulus in pediatric patients of any age.. These patients were diagnosed as having a midgut volvulus by operation at Ewha Womans University Hospital. Eleven patients (64.7 %) were less than 1 month of age, and fifteen were boys (88.2 %). The mean gestational age was 38.3 weeks and the birth weight was 3.1 kg. Eight patients (47.1 %) had one or more combined anomalies such as heart malformation, brain ischemia, Down's syndrome or duodenal atresia. Vomiting was the most common symptom. Only thirteen patients underwent preoperative diagnostic procedures; 13 abdominal sonography demonstrated the whirlpool sign in 8 patients, upper gastrointestinal tract roentgenography showed a cork-screw pattern in 7 patients, and barium enema or small bowel series demonstrated positive findings in 7 patients. A Ladd's procedure was was formed on all patients.. There was no mortality or severe morbidity such as short bowel syndrome. Midgut volvulus should be included in the differential diagnosis in any infant or child who presents with the symptoms of acute abdomen, especially with vomiting.

  • PDF

간호사의 직무 스트레스와 과민성 장 증후군에 관한 연구 (A Study on the Relationship between Irritable Bowel Syndrome(IBS) and Nurses' Occupational Stress)

  • 윤치근;이안생
    • 한국직업건강간호학회지
    • /
    • 제18권2호
    • /
    • pp.281-288
    • /
    • 2009
  • Purpose: This study was to investigate the relationship between IBS and nurses' occupational stress. Method: We used the modified Rome III criteria to measure the relationship between IBS and nurses' occupational stress. This questionnaire is composed of 9 areas and 43 items related to the stress. We collected the data of 395 respondents from W hospital. The survey was done from July 10th to July 31th, 2009. Results: The morbidity of IBS showed 24.3%. It was significantly influenced by night shift, and hospital visits and medication because of abdominal discomfort for the past 6 months. The causes of the nurses' occupational stress, which influenced the difference between IBS and non-IBS group, were "conflict with doctors" "difficulties in human relationships" "dealing with guardians and patients". The IBS group's stress was higher that of the non-IBS group. Also 96.9% of the IBS group and 79.3% of the non-IBS group responded there was relationship between IBS and nurses occupational stress. Conclusion: We found the relationship between IBS and nurses' occupational stress. And such stress could be reduced through the education about IBS.

  • PDF

In situ Delivery of Therapeutic Proteins by Recombinant Lactococcus lactis

  • Steidler, Lothar;Neirynck, Sabine
    • Journal of Microbiology
    • /
    • 제41권2호
    • /
    • pp.63-72
    • /
    • 2003
  • Chronic inflammatory bowel disease (IBD) such as Crohn's disease or ulcerative colitis, affects around 2 in every 1000 individuals in western countries and its incidence, particularly amongst children, is increasing. IBD shows extreme morbidity with impact on all aspects of quality of life. If left untreated, IBD can lead to death. Conventional treatment of IBD involves powerful immunosuppressive chemotherapies and surgical intervention. Long-term anti-inflammatory medication is required and so patients are often subject to a spectrum of unpleasant side effects. Interleukin-10 (IL-10) is a cytokine that acts to suppress inflammation. When however administered by injection, the high levels of IL-10 that are distributed throughout the body also lead to side effects. Lactococcus lactis can be genetically engineered to secrete biologically active cytokines. When applied to the mucosa, these L. lactis can actively deliver such cytokines. By use of this principle we developed a new therapeutic approach for IBD. Administration of L. lactis that secretes murine IL-10 cures and prevents IBD in mice. The use of the engineered L. lactis gets around the problem of delivering IL-10, allowing dramatic reduction of the effective dose. A sincere concern exists about the possible dangers of uncontrolled, deliberate release of genetically modified microorganisms, such as could occur following application in healthcare. We engaged in the establishment of adequate means for biological growth control of engineered L. lactis by targeted gene exchange between thyA and hIL-10.

Autophagy and Digestive Disorders: Advances in Understanding and Therapeutic Approaches

  • Thein, Wynn;Po, Wah Wah;Choi, Won Seok;Sohn, Uy Dong
    • Biomolecules & Therapeutics
    • /
    • 제29권4호
    • /
    • pp.353-364
    • /
    • 2021
  • The gastrointestinal (GI) tract is a series of hollow organs that is responsible for the digestion and absorption of ingested foods and the excretion of waste. Any changes in the GI tract can lead to GI disorders. GI disorders are highly prevalent in the population and account for substantial morbidity, mortality, and healthcare utilization. GI disorders can be functional, or organic with structural changes. Functional GI disorders include functional dyspepsia and irritable bowel syndrome. Organic GI disorders include inflammation of the GI tract due to chronic infection, drugs, trauma, and other causes. Recent studies have highlighted a new explanatory mechanism for GI disorders. It has been suggested that autophagy, an intracellular homeostatic mechanism, also plays an important role in the pathogenesis of GI disorders. Autophagy has three primary forms: macroautophagy, microautophagy, and chaperone-mediated autophagy. It may affect intestinal homeostasis, host defense against intestinal pathogens, regulation of the gut microbiota, and innate and adaptive immunity. Drugs targeting autophagy could, therefore, have therapeutic potential for treating GI disorders. In this review, we provide an overview of current understanding regarding the evidence for autophagy in GI diseases and updates on potential treatments, including drugs and complementary and alternative medicines.

Treatment Results of Small Intestinal Gastrointestinal Stromal Tumors Less than 10 cm in Diameter: A Comparison between Laparoscopy and Open Surgery

  • Ihn, Kyong;Hyung, Woo Jin;Kim, Hyoung-Il;An, Ji Yeong;Kim, Jong Won;Cheong, Jae-Ho;Yoon, Dong Sup;Choi, Seung Ho;Noh, Sung Hoon
    • Journal of Gastric Cancer
    • /
    • 제12권4호
    • /
    • pp.243-248
    • /
    • 2012
  • Purpose: To evaluate the technical feasibility and oncologic safety, we assessed the short-term and long-term outcomes of laparoscopic resection of the small bowel gastrointestinal stromal tumors smaller than 5 cm by comparing those of open surgery by subgroup analysis based on tumor size. Materials and Methods: From November 1993 to January 2011, 41 laparoscopic resections were performed among the 95 patients who underwent resection of small intestine ${\leq}10$ cm in diameter. The clinicopathologic features, perioperative outcomes, recurrences and survival of these patients were reviewed. Results: The postoperative morbidity rates were comparable between the 2 groups. Laparoscopic surgery group showed significantly shorter operative time (P=0.004) and duration of postoperative hospital stay (P<0.001) than open surgery group and it was more apparent in the smaller tumor size group. There were no difference in 5-year survival for the laparoscopic surgery versus open surgery groups (P=0.163), and in 5-year recurrence-free survival (P=0.262). The subgroup analysis by 5 cm in tumor size also shows no remarkable differences in 5-year survival and recurrence-free survival. Conclusions: Laparoscopic resection for small bowel gastrointestinal stromal tumors of size less than 10 cm has favorable short-term postoperative outcomes, while achieving comparable oncologic results compared with open surgery. Thus, laparoscopic approach can be recommended as a treatment modality for patients with small bowel gastrointestinal stromal tumors less than 10 cm in diameter.

Quality of Life in Children and Adolescents with Inflammatory Bowel Disease: Impact and Predictive Factors

  • Silva, Larissa Caetano;Seixas, Renata B.P. Melo;de Carvalho, Elisa
    • Pediatric Gastroenterology, Hepatology & Nutrition
    • /
    • 제23권3호
    • /
    • pp.286-296
    • /
    • 2020
  • Purpose: Inflammatory bowel disease (IBD) in children and adolescents is associated with high morbidity and possibly has a significant negative impact on their quality of life. This study aimed to evaluate the quality of life of children and adolescents with IBD and define the variables that impact these individuals. Methods: We administered the Pediatric Quality of Life Questionnaire (PedsQL) to 35 children and adolescents diagnosed with IBD and with available quantitative data from clinical records on epidemiology, clinical evolution, complementary tests, medical interventions, and disease activity. Data were evaluated according to the IBD type and compared with a control group of healthy children. Results: The study group showed a significantly lower PedsQL score than the control group (p<0.01). Significant factors contributing to poor overall quality of life included female sex, Crohn's disease, surgery, and food restrictions. Symptoms such as diarrhea and the fear of using public toilets were associated with low physical scores. Feeling sick had a negative impact on the emotional PedsQL scores. Patients with a fear of using public toilets, anthropometric scores below the 3rd percentile, and greater disease activity scored lower in the social domain. Regarding school and psychosocial evaluations, younger children with symptom onset after the age of 2 years had lower scores than younger children with symptom onset before the age of 2 years. Conclusion: IBD negatively affects the quality of life of children and adolescents based on its impact on the physical, emotional, social, and psychosocial statuses of these patients.

The Medical Treatments of Intestinal Behçet's Disease: An Update

  • Lee, Hye Won;Kim, Won Ho;Cheon, Jae Hee
    • Intestinal research
    • /
    • 제11권3호
    • /
    • pp.155-160
    • /
    • 2013
  • Behçet's disease (BD) is a systemic immunological disorder characterized by recurrent mucosal ulcerative lesions including oral and genital ulcerations in association with skin and ocular involvements. BD also can involve the gastrointestinal tract. Gastrointestinal involvement of BD is one of the major causes of morbidity and mortality for this disease. However, clinical data are quite limited because of the rarity of intestinal BD. Therefore, the management of intestinal BD is heavily dependent on expert opinions and standardized medical treatments of intestinal BD are yet to be established. In this brief review, the authors summarized the currently available medical treatments such as 5-aminosalicylic acids, corticosteroids, immuno-modulators, and anti-TNF agents. Moreover, we sought to suggest a treatment algorithm for intestinal BD based on the recently published and updated data.